The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determining barriers to effective data sharing in cancer genomic sequencing initiatives: A Global Alliance for Genomics and Health (GA4GH) survey.
 
Jeremy Howard Lewin
No Relationships to Disclose
 
Daniel J Vis
No Relationships to Disclose
 
Emile E. Voest
Consulting or Advisory Role - Biogeneration Ventures; InteRNA
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Rachel Liao
No Relationships to Disclose
 
Petra M Nederlof
No Relationships to Disclose
 
Barbara A. Conley
No Relationships to Disclose
 
David B. Solit
Honoraria - Loxo; Novartis; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Christopher L. Corless
Consulting or Advisory Role - Cepheid; Roche
 
Paulo V Campregher
No Relationships to Disclose
 
Vanessa Tyrell
No Relationships to Disclose
 
George Chong
No Relationships to Disclose
 
Michael Watson
Consulting or Advisory Role - ClinGen
 
Sun Young Rha
No Relationships to Disclose
 
Tim Maughan
No Relationships to Disclose
 
Mark Caulfield
No Relationships to Disclose
 
Vladimir Lazar
No Relationships to Disclose
 
Laura Esserman
Consulting or Advisory Role - Genentech (Inst)
Travel, Accommodations, Expenses - Genentech
 
Charles L. Sawyers
No Relationships to Disclose
 
Lillian L. Siu
Leadership - Agios (I)
Stock and Other Ownership Interests - Agios (I); Entremed (I)
Consulting or Advisory Role - Boehringer Ingelheim; Daiichi Sankyo; Merck; Novartis (Inst); Oncoethix
Research Funding - Abraxis BioScience; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Celgene; Genentech/Roche; GlaxoSmithKline; Karyopharm Therapeutics; MedImmune; Merck; Novartis; Pfizer; Regeneron
 
Mark Lawler
No Relationships to Disclose